Global Hepatic Encephalopathy (HE) Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

October 2018 | 118 pages | ID: G0E8A51B448EN
GlobalInfoResearch

Abstracts

HE is a potentially fatal brain disorder that is caused by liver damage, which results in the failure to remove toxins from the blood.

Scope of the Report:

This report focuses on the Hepatic Encephalopathy (HE) Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The availability of patient-focused programs to assist disease management is one of the primary growth drivers for the global hepatic encephalopathy (HE) therapeutics market till 2023. Such programs increase the adherence to therapeutics by improving convenience for patients. Norgine collaborated with the European liver patients association (ELPA) to launch Time to DeLiver program, which is focused on changing the perception about HE among all stakeholders, healthcare professionals, and policymakers. This in turn, drives the demand for diagnosis and management of HE.

The most commonly used therapeutics to treat HE are lactulose and rifaximin. Researchers are also developing treatments that targets ammonia production and removal. For instance, AST-120 is under investigation and targets gut-derived toxins for liver cirrhosis. It can also be used to treat HE. The progression and development of HE sometimes depends on factors such as inflammation. This is compelling researchers to introduce various treatments that targets inflammation. Some of the most recent approaches to treat HE includes probiotics, albumin administration, and dialysis. Such emergence of novel hepatic encephalopathy treatment targets is identified as one of the key trends that will stimulate growth in the hepatic encephalopathy (HE) therapeutics market during the forecasted period.

The worldwide market for Hepatic Encephalopathy (HE) Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• ASKA Pharmaceutical
• COSMO PHARMACEUTICALS
• Mallinckrodt
• Valeant

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Lactulose
• Rifaximin
• Neomycin
• Probiotics
• Thiamine

Market Segment by Applications, can be divided into

• Acute Liver Failure
• Portal Systemic Bypass Without Liver Disease
• Liver Cirrhosis

There are 15 Chapters to deeply display the global Hepatic Encephalopathy (HE) Therapeutics market.

Chapter 1, to describe Hepatic Encephalopathy (HE) Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Hepatic Encephalopathy (HE) Therapeutics, with sales, revenue, and price of Hepatic Encephalopathy (HE) Therapeutics, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Hepatic Encephalopathy (HE) Therapeutics, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Hepatic Encephalopathy (HE) Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Hepatic Encephalopathy (HE) Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Hepatic Encephalopathy (HE) Therapeutics Introduction
1.2 Market Analysis by Type
  1.2.1 Lactulose
  1.2.2 Rifaximin
  1.2.3 Neomycin
  1.2.4 Probiotics
  1.2.5 Thiamine
1.3 Market Analysis by Applications
  1.3.1 Acute Liver Failure
  1.3.2 Portal Systemic Bypass Without Liver Disease
  1.3.3 Liver Cirrhosis
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 ASKA Pharmaceutical
  2.1.1 Business Overview
  2.1.2 Hepatic Encephalopathy (HE) Therapeutics Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 ASKA Pharmaceutical Hepatic Encephalopathy (HE) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 COSMO PHARMACEUTICALS
  2.2.1 Business Overview
  2.2.2 Hepatic Encephalopathy (HE) Therapeutics Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 COSMO PHARMACEUTICALS Hepatic Encephalopathy (HE) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Mallinckrodt
  2.3.1 Business Overview
  2.3.2 Hepatic Encephalopathy (HE) Therapeutics Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Mallinckrodt Hepatic Encephalopathy (HE) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Valeant
  2.4.1 Business Overview
  2.4.2 Hepatic Encephalopathy (HE) Therapeutics Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Valeant Hepatic Encephalopathy (HE) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL HEPATIC ENCEPHALOPATHY (HE) THERAPEUTICS SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)

3.1 Global Hepatic Encephalopathy (HE) Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Hepatic Encephalopathy (HE) Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
  3.3.1 Top 3 Hepatic Encephalopathy (HE) Therapeutics Manufacturer Market Share in 2017
  3.3.2 Top 6 Hepatic Encephalopathy (HE) Therapeutics Manufacturer Market Share in 2017
3.4 Market Competition Trend

4 GLOBAL HEPATIC ENCEPHALOPATHY (HE) THERAPEUTICS MARKET ANALYSIS BY REGIONS

4.1 Global Hepatic Encephalopathy (HE) Therapeutics Sales, Revenue and Market Share by Regions
  4.1.1 Global Hepatic Encephalopathy (HE) Therapeutics Sales and Market Share by Regions (2013-2018)
  4.1.2 Global Hepatic Encephalopathy (HE) Therapeutics Revenue and Market Share by Regions (2013-2018)
4.2 North America Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
4.3 Europe Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
4.5 South America Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)

5 NORTH AMERICA HEPATIC ENCEPHALOPATHY (HE) THERAPEUTICS BY COUNTRIES

5.1 North America Hepatic Encephalopathy (HE) Therapeutics Sales, Revenue and Market Share by Countries
  5.1.1 North America Hepatic Encephalopathy (HE) Therapeutics Sales and Market Share by Countries (2013-2018)
  5.1.2 North America Hepatic Encephalopathy (HE) Therapeutics Revenue and Market Share by Countries (2013-2018)
5.2 United States Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
5.3 Canada Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
5.4 Mexico Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)

6 EUROPE HEPATIC ENCEPHALOPATHY (HE) THERAPEUTICS BY COUNTRIES

6.1 Europe Hepatic Encephalopathy (HE) Therapeutics Sales, Revenue and Market Share by Countries
  6.1.1 Europe Hepatic Encephalopathy (HE) Therapeutics Sales and Market Share by Countries (2013-2018)
  6.1.2 Europe Hepatic Encephalopathy (HE) Therapeutics Revenue and Market Share by Countries (2013-2018)
6.2 Germany Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
6.3 UK Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
6.4 France Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
6.5 Russia Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
6.6 Italy Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)

7 ASIA-PACIFIC HEPATIC ENCEPHALOPATHY (HE) THERAPEUTICS BY COUNTRIES

7.1 Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Sales and Market Share by Countries (2013-2018)
  7.1.2 Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Revenue and Market Share by Countries (2013-2018)
7.2 China Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
7.3 Japan Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
7.4 Korea Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
7.5 India Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)

8 SOUTH AMERICA HEPATIC ENCEPHALOPATHY (HE) THERAPEUTICS BY COUNTRIES

8.1 South America Hepatic Encephalopathy (HE) Therapeutics Sales, Revenue and Market Share by Countries
  8.1.1 South America Hepatic Encephalopathy (HE) Therapeutics Sales and Market Share by Countries (2013-2018)
  8.1.2 South America Hepatic Encephalopathy (HE) Therapeutics Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
8.3 Argentina Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
8.4 Colombia Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA HEPATIC ENCEPHALOPATHY (HE) THERAPEUTICS BY COUNTRIES

9.1 Middle East and Africa Hepatic Encephalopathy (HE) Therapeutics Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Hepatic Encephalopathy (HE) Therapeutics Sales and Market Share by Countries (2013-2018)
  9.1.2 Middle East and Africa Hepatic Encephalopathy (HE) Therapeutics Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
9.3 UAE Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
9.4 Egypt Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
9.5 Nigeria Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
9.6 South Africa Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)

10 GLOBAL HEPATIC ENCEPHALOPATHY (HE) THERAPEUTICS MARKET SEGMENT BY TYPE

10.1 Global Hepatic Encephalopathy (HE) Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Hepatic Encephalopathy (HE) Therapeutics Sales and Market Share by Type (2013-2018)
  10.1.2 Global Hepatic Encephalopathy (HE) Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Lactulose Sales Growth and Price
  10.2.1 Global Lactulose Sales Growth (2013-2018)
  10.2.2 Global Lactulose Price (2013-2018)
10.3 Rifaximin Sales Growth and Price
  10.3.1 Global Rifaximin Sales Growth (2013-2018)
  10.3.2 Global Rifaximin Price (2013-2018)
10.4 Neomycin Sales Growth and Price
  10.4.1 Global Neomycin Sales Growth (2013-2018)
  10.4.2 Global Neomycin Price (2013-2018)
10.5 Probiotics Sales Growth and Price
  10.5.1 Global Probiotics Sales Growth (2013-2018)
  10.5.2 Global Probiotics Price (2013-2018)
10.6 Thiamine Sales Growth and Price
  10.6.1 Global Thiamine Sales Growth (2013-2018)
  10.6.2 Global Thiamine Price (2013-2018)

11 GLOBAL HEPATIC ENCEPHALOPATHY (HE) THERAPEUTICS MARKET SEGMENT BY APPLICATION

11.1 Global Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Application (2013-2018)
11.2 Acute Liver Failure Sales Growth (2013-2018)
11.3 Portal Systemic Bypass Without Liver Disease Sales Growth (2013-2018)
11.4 Liver Cirrhosis Sales Growth (2013-2018)

12 HEPATIC ENCEPHALOPATHY (HE) THERAPEUTICS MARKET FORECAST (2018-2023)

12.1 Global Hepatic Encephalopathy (HE) Therapeutics Sales, Revenue and Growth Rate (2018-2023)
12.2 Hepatic Encephalopathy (HE) Therapeutics Market Forecast by Regions (2018-2023)
  12.2.1 North America Hepatic Encephalopathy (HE) Therapeutics Market Forecast (2018-2023)
  12.2.2 Europe Hepatic Encephalopathy (HE) Therapeutics Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Market Forecast (2018-2023)
  12.2.4 South America Hepatic Encephalopathy (HE) Therapeutics Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Hepatic Encephalopathy (HE) Therapeutics Market Forecast (2018-2023)
12.3 Hepatic Encephalopathy (HE) Therapeutics Market Forecast by Type (2018-2023)
  12.3.1 Global Hepatic Encephalopathy (HE) Therapeutics Sales Forecast by Type (2018-2023)
  12.3.2 Global Hepatic Encephalopathy (HE) Therapeutics Market Share Forecast by Type (2018-2023)
12.4 Hepatic Encephalopathy (HE) Therapeutics Market Forecast by Application (2018-2023)
  12.4.1 Global Hepatic Encephalopathy (HE) Therapeutics Sales Forecast by Application (2018-2023)
  12.4.2 Global Hepatic Encephalopathy (HE) Therapeutics Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Hepatic Encephalopathy (HE) Therapeutics Picture
Table Product Specifications of Hepatic Encephalopathy (HE) Therapeutics
Figure Global Sales Market Share of Hepatic Encephalopathy (HE) Therapeutics by Types in 2017
Table Hepatic Encephalopathy (HE) Therapeutics Types for Major Manufacturers
Figure Lactulose Picture
Figure Rifaximin Picture
Figure Neomycin Picture
Figure Probiotics Picture
Figure Thiamine Picture
Figure Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Applications in 2017
Figure Acute Liver Failure Picture
Figure Portal Systemic Bypass Without Liver Disease Picture
Figure Liver Cirrhosis Picture
Figure United States Hepatic Encephalopathy (HE) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Hepatic Encephalopathy (HE) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Hepatic Encephalopathy (HE) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Hepatic Encephalopathy (HE) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure France Hepatic Encephalopathy (HE) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure UK Hepatic Encephalopathy (HE) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Hepatic Encephalopathy (HE) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Hepatic Encephalopathy (HE) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure China Hepatic Encephalopathy (HE) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Hepatic Encephalopathy (HE) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Hepatic Encephalopathy (HE) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure India Hepatic Encephalopathy (HE) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Hepatic Encephalopathy (HE) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Hepatic Encephalopathy (HE) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Hepatic Encephalopathy (HE) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Hepatic Encephalopathy (HE) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Hepatic Encephalopathy (HE) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Hepatic Encephalopathy (HE) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Table ASKA Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table ASKA Pharmaceutical Hepatic Encephalopathy (HE) Therapeutics Type and Applications
Table ASKA Pharmaceutical Hepatic Encephalopathy (HE) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table COSMO PHARMACEUTICALS Basic Information, Manufacturing Base and Competitors
Table COSMO PHARMACEUTICALS Hepatic Encephalopathy (HE) Therapeutics Type and Applications
Table COSMO PHARMACEUTICALS Hepatic Encephalopathy (HE) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table Mallinckrodt Hepatic Encephalopathy (HE) Therapeutics Type and Applications
Table Mallinckrodt Hepatic Encephalopathy (HE) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Valeant Basic Information, Manufacturing Base and Competitors
Table Valeant Hepatic Encephalopathy (HE) Therapeutics Type and Applications
Table Valeant Hepatic Encephalopathy (HE) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Hepatic Encephalopathy (HE) Therapeutics Sales by Manufacturer (2016-2017)
Figure Global Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Manufacturer in 2016
Figure Global Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Manufacturer in 2017
Table Global Hepatic Encephalopathy (HE) Therapeutics Revenue by Manufacturer (2016-2017)
Figure Global Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Global Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Manufacturer in 2017
Figure Top 3 Hepatic Encephalopathy (HE) Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Hepatic Encephalopathy (HE) Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Global Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure Global Hepatic Encephalopathy (HE) Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Hepatic Encephalopathy (HE) Therapeutics Sales by Regions (2013-2018)
Table Global Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Regions (2013-2018)
Table Global Hepatic Encephalopathy (HE) Therapeutics Revenue by Regions (2013-2018)
Figure Global Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Regions in 2013
Figure Global Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Regions in 2017
Figure North America Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure Europe Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure South America Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure North America Hepatic Encephalopathy (HE) Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Hepatic Encephalopathy (HE) Therapeutics Sales by Countries (2013-2018)
Table North America Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Countries (2013-2018)
Figure North America Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Countries in 2013
Figure North America Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Countries in 2017
Table North America Hepatic Encephalopathy (HE) Therapeutics Revenue by Countries (2013-2018)
Table North America Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Countries in 2013
Figure North America Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Countries in 2017
Figure United States Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure Canada Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure Mexico Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure Europe Hepatic Encephalopathy (HE) Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Hepatic Encephalopathy (HE) Therapeutics Sales by Countries (2013-2018)
Table Europe Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Countries (2013-2018)
Table Europe Hepatic Encephalopathy (HE) Therapeutics Revenue by Countries (2013-2018)
Figure Europe Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Countries in 2016
Figure Europe Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure UK Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure France Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure Russia Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure Italy Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Sales by Countries (2013-2018)
Table Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Countries 2017
Table Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Revenue by Countries (2013-2018)
Figure Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Countries 2017
Figure China Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure Japan Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure Korea Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure India Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure Southeast Asia Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure South America Hepatic Encephalopathy (HE) Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Hepatic Encephalopathy (HE) Therapeutics Sales by Countries (2013-2018)
Table South America Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Countries (2013-2018)
Figure South America Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Countries in 2017
Table South America Hepatic Encephalopathy (HE) Therapeutics Revenue by Countries (2013-2018)
Table South America Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure Argentina Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure Colombia Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Hepatic Encephalopathy (HE) Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Hepatic Encephalopathy (HE) Therapeutics Sales by Countries (2013-2018)
Table Middle East and Africa Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Hepatic Encephalopathy (HE) Therapeutics Sales Market Share by Countries in 2017
Table Middle East and Africa Hepatic Encephalopathy (HE) Therapeutics Revenue by Countries (2013-2018)
Table Middle East and Africa Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Countries in 2013
Figure Middle East and Africa Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure UAE Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure Egypt Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure Nigeria Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Figure South Africa Hepatic Encephalopathy (HE) Therapeutics Sales and Growth Rate (2013-2018)
Table Global Hepatic Encephalopathy (HE) Therapeutics Sales by Type (2013-2018)
Table Global Hepatic Encephalopathy (HE) Therapeutics Sales Share by Type (2013-2018)
Table Global Hepatic Encephalopathy (HE) Therapeutics Revenue by Type (2013-2018)
Table Global Hepatic Encephalopathy (HE) Therapeutics Revenue Share by Type (2013-2018)
Figure Global Lactulose Sales Growth (2013-2018)
Figure Global Lactulose Price (2013-2018)
Figure Global Rifaximin Sales Growth (2013-2018)
Figure Global Rifaximin Price (2013-2018)
Figure Global Neomycin Sales Growth (2013-2018)
Figure Global Neomycin Price (2013-2018)
Figure Global Probiotics Sales Growth (2013-2018)
Figure Global Probiotics Price (2013-2018)
Figure Global Thiamine Sales Growth (2013-2018)
Figure Global Thiamine Price (2013-2018)
Table Global Hepatic Encephalopathy (HE) Therapeutics Sales by Application (2013-2018)
Table Global Hepatic Encephalopathy (HE) Therapeutics Sales Share by Application (2013-2018)
Figure Global Portal Systemic Bypass Without Liver Disease Sales Growth (2013-2018)
Figure Global Liver Cirrhosis Sales Growth (2013-2018)
Figure Global Hepatic Encephalopathy (HE) Therapeutics Sales, Revenue and Growth Rate (2018-2023)
Table Global Hepatic Encephalopathy (HE) Therapeutics Sales Forecast by Regions (2018-2023)
Table Global Hepatic Encephalopathy (HE) Therapeutics Market Share Forecast by Regions (2018-2023)
Figure North America Sales Hepatic Encephalopathy (HE) Therapeutics Market Forecast (2018-2023)
Figure Europe Sales Hepatic Encephalopathy (HE) Therapeutics Market Forecast (2018-2023)
Figure Asia-Pacific Sales Hepatic Encephalopathy (HE) Therapeutics Market Forecast (2018-2023)
Figure South America Sales Hepatic Encephalopathy (HE) Therapeutics Market Forecast (2018-2023)
Figure Middle East and Africa Sales Hepatic Encephalopathy (HE) Therapeutics Market Forecast (2018-2023)
Table Global Hepatic Encephalopathy (HE) Therapeutics Sales Forecast by Type (2018-2023)
Table Global Hepatic Encephalopathy (HE) Therapeutics Market Share Forecast by Type (2018-2023)
Table Global Hepatic Encephalopathy (HE) Therapeutics Sales Forecast by Application (2018-2023)
Table Global Hepatic Encephalopathy (HE) Therapeutics Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List